SAG
BSX icon

SageView Advisory Group’s Boston Scientific BSX Stock Holding History

SageView Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,411
Closed -$214K – 620
2026
Q1 		$214K Sell
3,411
-4,394
-56% -$352K 0.01% 560
2025
Q4 		$744K Sell
7,805
-2,770
-26% -$272K 0.03% 294
2025
Q3 		$1.03M Sell
10,575
-224
-2% -$23.2K 0.04% 264
2025
Q2 		$1.14M Buy
10,799
+386
+4% +$39.1K 0.04% 224
2025
Q1 		$1.05M Buy
10,413
+702
+7% +$70.7K 0.04% 218
2024
Q4 		$867K Buy
9,711
+450
+5% +$39.6K 0.04% 242
2024
Q3 		$776K Buy
9,261
+259
+3% +$20.4K 0.04% 230
2024
Q2 		$693K Buy
9,002
+820
+10% +$60K 0.03% 282
2024
Q1 		$560K Sell
8,182
-1,396
-15% -$89.8K 0.03% 301
2023
Q4 		$588K Buy
+9,578
New +$511K 0.03% 361

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SageView Advisory Group's BSX Position: Q2 2026 in Review

SageView Advisory Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,411 shares — an estimated $214K sold.

SageView Advisory Group first reported a position in BSX in Q4 2023 and held it in 10 quarters. The position peaked at $1.14M in Q2 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • SageView Advisory Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • SageView Advisory Group sold 3,411 Boston Scientific shares in Q2 2026, an estimated $214K.
  • SageView Advisory Group first reported a position in Boston Scientific in Q4 2023 and held it in 10 quarters.
  • SageView Advisory Group's Boston Scientific position peaked at $1.14M in Q2 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.